GeneCentric Diagnostics Labcorp, GeneCentric Partnering on Development of RNA-Based Cancer Diagnostics The parties will use retrospective analyses of Labcorp samples, and Labcorp will deploy tests produced through the project to academic and community cancer centers. GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer GeneCentric and Erasmus will aim to identify RNA-based drug response markers for existing bladder cancer treatments, as well as discover novel targeted therapies. Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership The collaboration seeks to develop RNA-based signatures that could help oncologists predict disease progression and guide the use of precision therapies. GeneCentric Therapeutics to Launch Phase II Validation Study for Head and Neck Cancer Subtyper Premium The firm is developing a biomarker panel to detect mutations in mesenchymal cells, with the goal of guiding drug treatment and improving earlier patient intervention. GeneCentric, UNC Collaborate on Bladder Cancer Immunotherapy Response Study The partners will evaluate patients' responses to immunotherapeutic drugs, including PD-1 and PDL-1 inhibitors, based on bladder cancer subtypes. Sep 24, 2018 GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech Jun 22, 2018 GeneCentric Builds Expression-Based Subtypes for New Cancer Types Premium Jan 6, 2017 Bristol-Myers Squibb, GeneCentric To Collaborate on Opdivo Biomarker Study Breaking News Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test 3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.